share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

SEC announcement ·  Apr 17 04:17
Summary by Futu AI
On April 15, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock. The transaction involved the acquisition of 13 shares at a price of $750.77 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,627 shares. The transaction is reported to have been completed successfully, with no subsequent sales reported.
On April 15, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock. The transaction involved the acquisition of 13 shares at a price of $750.77 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,627 shares. The transaction is reported to have been completed successfully, with no subsequent sales reported.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.